Intestinal Microbiota as a Contributor to Chronic Inflammation and Its Potential Modifications

Abstract

The gut microbiota is a crucial factor in maintaining homeostasis. The presence of commensal microorganisms leads to the stimulation of the immune system and its maturation. In turn, dysbiosis with an impaired intestinal barrier leads to accelerated contact of microbiota with the host’s immune cells. Microbial structural parts, i.e., pathogen-associated molecular patterns (PAMPs), such as flagellin (FLG), peptidoglycan (PGN), lipoteichoic acid (LTA), and lipopolysaccharide (LPS), induce inflammation via activation of pattern recognition receptors. Microbial metabolites can also develop chronic low-grade inflammation, which is the cause of many metabolic diseases. This article aims to systematize information on the influence of microbiota on chronic inflammation and the benefits of microbiota modification through dietary changes, prebiotics, and probiotic intake. Scientific research indicates that the modification of the microbiota in various disease states can reduce inflammation and improve the metabolic profile. However, since there is no pattern for a healthy microbiota, there is no optimal way to modify it. The methods of influencing microbiota should be adapted to the type of dysbiosis. Although there are studies on the microbiota and its effects on inflammation, this subject is still relatively unknown, and more research is needed in this area.

The Nutrition-Microbiota-Physical Activity Triad: An Inspiring New Concept for Health and Sports Performance

“…Local inflammation is triggered, and the intestinal wall permeability increases. LPS can then pass through the intestinal wall, enter the bloodstream, and cause systemic inflammation in other target tissues [ 21 ].…”

Gender‐based effect of absence of gut microbiota on the protective efficacy of Bifidobacterium longum‐fermented rice bran diet against inflammation‐associated colon tumorigenesis

“…Colorectal cancer (CRC) is the 2nd leading cause of cancer-related deaths in United States 1 and develops as a result of complex interactions between microbiota, dietary components, and gut mucosal immune/inflammatory mediators. [2][3][4] Multiple research efforts have associated the differential impact of human gut microbiota and microbiota-associated metabolism changes with CRC. 2,3,[5][6][7][8][9] Given the high CRC incidence and mortality statistics, host and environmental factors that affect CRC, alongside novel agents that modulate host and gut microbial metabolism merit attention to reduce CRC.…”

A Panax quinquefolius-Based Preparation Prevents the Impact of 5-FU on Activity/Exploration Behaviors and Not on Cognitive Functions Mitigating Gut Microbiota and Inflammation in Mice

“…It was previously shown that intestinal inflammation and, in particular, pro-inflammatory cytokine secretion are correlated with changes in the composition of gut microbiota [ 59 , 64 ]. We made a correlation study between the different bacterial taxa quantified in the cecum and plasma cytokine levels ( Figure 7 C).…”